Welcome to the e-CCO Library!

P0595: Comparative effectiveness between ustekinumab and vedolizumab after anti-TNF failure in Ulcerative Colitis: Real-world experience
Year: 2025
Source: ECCO'25
Authors: Jairathx7x7x7 R.(1)*;Zoughlamix7x7x7 A.(1);Mahmoudx7x7x7 O.(2);Pilotex7x7x7 N.(3);Solitanox7x7x7 V.(4x7x7x75);Mohammadx7x7x7 D.(6);Afifx7x7x7 W.(1);Bittonx7x7x7 A.(1);Wildx7x7x7 G.(1);Lakatosx7x7x7 P.L.(1);Narulax7x7x7 N.(7);Jairathx7x7x7 V.(4);Bessissowx7x7x7 T.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0596: Fecal bile acids predict the therapeutic effect of biological agents in patients with ulcerative colitis
Year: 2025
Source: ECCO'25
Authors: Guox7x7x7 J.(1);Yuanx7x7x7 X.(1);Lix7x7x7 C.(1)*;Zhangx7x7x7 X.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0597: Clinical and biochemical correlates of infliximab pharmacokinetics in adult patients with Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Poolx7x7x7 I.A.(1);Volkerinkx7x7x7 I.(2);Stavastx7x7x7 M.(2);Kosterinkx7x7x7 J.G.W.(2);Dijkstrax7x7x7 G.(1);Mianx7x7x7 P.(2);Bourgonjex7x7x7 A.R.(1x7x7x73)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0598: Feasibility and limitations in adopting treat-to-target approach in inflammatory bowel diseases (IBD): real-life scenario
Year: 2025
Source: ECCO'25
Authors: Harindranathx7x7x7 S.(1)*;Desaix7x7x7 D.C.(1);Mehtax7x7x7 N.(1);Abrahamx7x7x7 P.(1);Guptax7x7x7 T.(1);Dhoblex7x7x7 P.(1);Mehendalex7x7x7 S.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0599: Efficacy and safety of intravenous methylprednisolone and hydrocortisone in Acute Severe Ulcerative Colitis (ASUC) – a posthoc analysis of the IASO trial
Year: 2025
Source: ECCO'25
Authors: Thakorx7x7x7 A.(1)*;Drobne x7x7x7 D.(2);Vajax7x7x7 S.(3);Subramanianx7x7x7 S.(1);Qianx7x7x7 W.(3);Davis-Wilkiex7x7x7 C.(3);Parkesx7x7x7 M.(1);Kaserx7x7x7 A.(1);Rainex7x7x7 T.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P059: Diet controls segmented filamentous bacteria in driving Crohn’s disease-like inflammation in TNFdeltaARE mice
Year: 2022
Source: ECCO'22
Authors: Metwaly, A.(1);Calasan, J.(1);Waldschmitt, N.(1);Khaloian, S.(1);Häcker, D.(1);Ahmed, M.(1);F. Butto, L.(1); Hammoudi, N.(2); Le Bourhis, L.(2);Mayorgas, A.(3);Siebert, K.(4);Basic, M.(5);Zeissig, S.(6);Schwerd, T.(4);Allez, M.(2);Panes, J.(3);Salas, A.(3); Bleich, A.(5);Cominelli, F.(7);Haller, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P059: GB004 drives protective effects on immune cells and epithelial cells using human ex vivo monolayer and co-culture systems
Year: 2021
Source: ECCO'21 Virtual
Authors: Taylor Meadows, K.(1);Murphy, S.(1);Levesque, B.G.(2);Carter, L.L.(3);Salter-Cid, L.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P059: Klebicin as a novel therapy for Klebsiella infection management
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Karaliute, I.(1)*;Tilinde, D.(1);Ramonaite, R.(1);Kupcinskas, J.(2);Misiunas, A.(3);Denkovskiene, E.(3);Gleba, Y.(4);Razanskiene, A.(3);Skieceviciene, J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P059: Mucosal inflammation promotes activation of circulating Vδ2+ T-cells in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

McCarthy N.*1, Gordon H.1, Rahman S.1, Harrow P.1,2, Stagg A.1, Lindsay J.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P059: Test of stability in stool extracts for F-calprotectin
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Aardal Eriksson*, J. Andersson

Created: Thursday, 21 February 2019, 9:14 AM
P059: The metformin inhibits MDSC and M2 macrophage via AMPK-induced inhibition of HMG-CoA reductase in tumour microenvironment of colitic cancer
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Y. Kang1, Y. H. Park1, S. J. Park1, J. H. Cheon1, W. H. Kim1, T. I. Kim*1

Created: Friday, 22 February 2019, 9:41 AM
P059: Two new genetic mouse models for ulcerative colitis based on lateral tight junction disruption.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

W. Stremmel*1, S. Staffer2, M. Schneider3, H. Gan-Schreier2, A. Wannhoff2, A. Gauss4, H. Wolburg5, M. Bach6, A. Swidsinski7, T. Efferth3

Created: Friday, 22 February 2019, 9:49 AM
P060 The pharmacologic inhibition of store-operated calcium entry pathway in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Letizia1, C. Yerinde1, A. Sand1, S. Schlickeiser2, U. Kaufmann3, B. Siegmund1, S. Feske3, C. Weidinger1

Created: Thursday, 30 January 2020, 10:12 AM
P0600: Do GI Quant small bowel motility values correlate with reported MR enterography findings in Crohn's disease?
Year: 2025
Source: ECCO'25
Authors: Macphersonx7x7x7 S.(1)*;Ballantynex7x7x7 S.(2);Brownsonx7x7x7 E.(3);Campbellx7x7x7 I.(4);Robertsonx7x7x7 A.(3);Hallx7x7x7 M.(5);Menysx7x7x7 A.(6);Seenanx7x7x7 J.P.(4);MacDonaldx7x7x7 J.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0601: Is advanced combination therapy effective in patients with refractory Inflammatory Bowel Disease?
Year: 2025
Source: ECCO'25
Authors: Rodríguez Gallardox7x7x7 M.(1)*;Valdés Delgadox7x7x7 T.(1);Maldonado Pérezx7x7x7 B.(1);Belvis Jiménezx7x7x7 M.(1);Aguado Paredesx7x7x7 A.(2);Castro Lariax7x7x7 L.(1);Argüelles Ariasx7x7x7 F.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0602: Long-term effectiveness and safety of ustekinumab dose escalation in patients with refractory ulcerative colitis: a multicenter retrospective cohort study
Year: 2025
Source: ECCO'25
Authors: Van Lieropx7x7x7 L.(1)*;Albinox7x7x7 L.(1);Rosentreterx7x7x7 R.(2);Thomasx7x7x7 P.W.A.(3);Lux7x7x7 C.(4);Siffledeenx7x7x7 J.(1);Kroekerx7x7x7 K.I.(1);Max7x7x7 C.(4);Peeranix7x7x7 F.(1);Halloranx7x7x7 B.P.(1);Baumgartx7x7x7 D.C.(1);Dielemanx7x7x7 L.A.(1);Dux7x7x7 L.(1);Hoentjenx7x7x7 F.(1);Wongx7x7x7 K.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0603: The real-world use of intravenous and subcutaneous Vedolizumab in IBD across Australia and New Zealandx7x7x7 Crohn’s Colitis Cure Data Insight’s Program.
Year: 2025
Source: ECCO'25
Authors: Sux7x7x7 W.K.(1x7x7x72x7x7x73);Wilsonx7x7x7 W.(4);Warkx7x7x7 G.(5);Ghalyx7x7x7 S.(6x7x7x77);Lynchx7x7x7 K.(8x7x7x79);Lawrancex7x7x7 I.(10x7x7x711);Walkerx7x7x7 G.(12x7x7x713x7x7x714);Forbesx7x7x7 A.(15);Brettx7x7x7 L.(16);Anx7x7x7 Y.K.(17x7x7x718);Connorx7x7x7 S.J.(3x7x7x75x7x7x719)*;Andrewsx7x7x7 J.M.(3x7x7x78x7x7x79);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0604: Frequency and Analysis of Deep Remission in Patients with Ulcerative Colitis: A Single-Center Retrospective Study
Year: 2025
Source: ECCO'25
Authors: Philippe Poncex7x7x7 M.(1)*;Guinea Lagunes x7x7x7 A.(1);Contreras Avilesx7x7x7 E.(1);Almeida del Pradox7x7x7 G.(1);López Perezx7x7x7 R.(1);Villanueva Herrerox7x7x7 J.(1);Jiménez Bobadillax7x7x7 B.(2);Sebastian Ocampo x7x7x7 V.(1);De Leon Rendonx7x7x7 J.L.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0605: Nutritional Therapy for IBD: a new non-profit organization that offers trustedx7x7x7 evidence-based information and novel resources on diet and nutritional therapies in IBD
Year: 2025
Source: ECCO'25
Authors: Pradosx7x7x7 A.(1x7x7x72)*;Sigall-Bonehx7x7x7 R.(3x7x7x74);Goldx7x7x7 S.(5);Haskeyx7x7x7 N.(6);Dayx7x7x7 A.(7);Beallx7x7x7 K.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0606: The efficacy of upadacitinib in Intestinal Behçet's Disease refractory to anti-TNF-α therapy in a retrospective study
Year: 2025
Source: ECCO'25
Authors: Lux7x7x7 J.(1);Fangx7x7x7 Y.(1);Dux7x7x7 J.(1);Chenx7x7x7 C.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session